These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 9057113

  • 1. Molecular anatomy of the development of the human substantia nigra.
    Aubert I, Brana C, Pellevoisin C, Giros B, Caille I, Carles D, Vital C, Bloch B.
    J Comp Neurol; 1997 Mar 03; 379(1):72-87. PubMed ID: 9057113
    [Abstract] [Full Text] [Related]

  • 2. Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
    Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y.
    Neuroscience; 1990 Mar 03; 37(2):387-98. PubMed ID: 1983469
    [Abstract] [Full Text] [Related]

  • 3. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain.
    Gross J, Andersson K, Chen Y, Müller I, Andreeva N, Herrera-Marschitz M.
    Brain Res Mol Brain Res; 2005 Apr 04; 134(2):275-81. PubMed ID: 15836923
    [Abstract] [Full Text] [Related]

  • 4. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F, Faucheux BA, Marquez J, Villares J, Menard JF, Agid Y, Hirsch EC.
    Brain Res; 1995 Sep 18; 692(1-2):233-43. PubMed ID: 8548309
    [Abstract] [Full Text] [Related]

  • 5. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN, Ryoo H, Cox C, Lu W.
    J Comp Neurol; 1995 Nov 20; 362(3):400-10. PubMed ID: 8576447
    [Abstract] [Full Text] [Related]

  • 6. Nuclear organization of the substantia nigra, ventral tegmental area and retrorubral field of the common marmoset (Callithrix jacchus): A cytoarchitectonic and TH-immunohistochemistry study.
    Cavalcanti JRLP, Pontes ALB, Fiuza FP, Silva KDA, Guzen FP, Lucena EES, Nascimento-Júnior ES, Cavalcante JC, Costa MSMO, Engelberth RCGJ, Cavalcante JS.
    J Chem Neuroanat; 2016 Nov 20; 77():100-109. PubMed ID: 27292410
    [Abstract] [Full Text] [Related]

  • 7. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat.
    Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA.
    Neuroscience; 2008 Apr 09; 152(4):1024-31. PubMed ID: 18355970
    [Abstract] [Full Text] [Related]

  • 8. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse.
    Bayer SA, Wills KV, Triarhou LC, Ghetti B.
    Exp Brain Res; 1995 Apr 09; 105(2):191-9. PubMed ID: 7498372
    [Abstract] [Full Text] [Related]

  • 9. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K, Czyrak A, Maćkowiak M, Fijał K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 09; 353(5):517-27. PubMed ID: 8740145
    [Abstract] [Full Text] [Related]

  • 10. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons.
    Weiss-Wunder LT, Chesselet MF.
    Neuroscience; 1992 Jul 09; 49(2):297-305. PubMed ID: 1359452
    [Abstract] [Full Text] [Related]

  • 11. Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.
    Rots NY, Cools AR, Bérod A, Voorn P, Rostène W, de Kloet ER.
    Brain Res; 1996 Feb 26; 710(1-2):189-96. PubMed ID: 8963658
    [Abstract] [Full Text] [Related]

  • 12. Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine.
    Spangler R, Goddard NL, Avena NM, Hoebel BG, Leibowitz SF.
    Brain Res Mol Brain Res; 2003 Mar 17; 111(1-2):74-83. PubMed ID: 12654507
    [Abstract] [Full Text] [Related]

  • 13. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I, Ghorayeb I, Normand E, Bloch B.
    J Comp Neurol; 2000 Feb 28; 418(1):22-32. PubMed ID: 10701753
    [Abstract] [Full Text] [Related]

  • 14. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
    Haber SN, Groenewegen HJ.
    J Comp Neurol; 1989 Dec 01; 290(1):53-68. PubMed ID: 2480370
    [Abstract] [Full Text] [Related]

  • 15. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ.
    Mov Disord; 1997 Nov 01; 12(6):885-97. PubMed ID: 9399211
    [Abstract] [Full Text] [Related]

  • 16. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
    Adelbrecht C, Agid Y, Raisman-Vozari R.
    Brain Res Mol Brain Res; 1996 Dec 31; 43(1-2):291-300. PubMed ID: 9037545
    [Abstract] [Full Text] [Related]

  • 17. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation.
    Caillé I, Dumartin B, Bloch B.
    Brain Res; 1996 Aug 19; 730(1-2):17-31. PubMed ID: 8883884
    [Abstract] [Full Text] [Related]

  • 18. Evolutionarily conserved organization of the dopaminergic system in lamprey: SNc/VTA afferent and efferent connectivity and D2 receptor expression.
    Pérez-Fernández J, Stephenson-Jones M, Suryanarayana SM, Robertson B, Grillner S.
    J Comp Neurol; 2014 Dec 01; 522(17):3775-94. PubMed ID: 24942187
    [Abstract] [Full Text] [Related]

  • 19. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B, Rothwell LA, Seabrook GR.
    Br J Pharmacol; 1994 Jul 01; 112(3):873-80. PubMed ID: 7921615
    [Abstract] [Full Text] [Related]

  • 20. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB, Bennett JP.
    Brain Res Dev Brain Res; 1996 Jul 20; 94(2):109-20. PubMed ID: 8836569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.